Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer

Category Primary study
JournalBreast
Year 2021
This article has no abstract
Epistemonikos ID: 69ca21ca1a8181e99e4167c23045252168f53982
First added on: Feb 13, 2025